NCT05157581 2025-12-30
ECP
University of Pittsburgh
Recruiting
Clinical Trials
9 trialsNCT04930653 2025-10-14
Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
City of Hope Medical Center
Phase 2 Recruiting
NCT00179855 2025-02-12
Extracorporeal Photopheresis for Acute Graft Versus Host Disease
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 2/3 Completed
NCT04676087 2024-08-13
Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides
Emory University
Phase 1/2 Terminated
NCT00179790 2017-03-06
Reduced Intensity Transplant Using Extracorporeal Photopheresis
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 1/2 Completed
NCT00402714 2017-01-18
A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies
Yale University
Phase 2 Completed
NCT01174940 2017-01-09
Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease
University of Kansas Medical Center
Phase EARLY_PHASE1 Completed
NCT00265603 2014-01-16
Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer
Atlantic Health System
Phase 1 Terminated
NCT00306969 2006-03-27
Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma
Boston University
Phase 1/2 Completed